MedTrace Logo

Mg OSTEOCRETE Post-Treatment Outcomes

NCT06720142 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 10

Last updated 2026-04-22

No results posted yet for this study

Summary

Mg OSTEOCRETE is a bone substitute used to fill a defect in bone caused by excision of a tumor, orthopaedic hardware that has become loosened, or a trauma-related condition. The aim of this study is to determine the amount of time it takes for bone to heal after treatment with Mg OSTEOCRETE, and to better understand the efficacy of this treatment through clinical and patient-reported outcomes.

Conditions

  • Cancer of Bone
  • Trauma
  • Aseptic Loosening of Orthopaedic Hardware

Interventions

DEVICE

Mg OSTEOCRETE as a bone void filler

Patients will be treated with Mg OSTEOCRETE as per standard clinical care to fill defects in bone left by bone tumor resection

DEVICE

Mg OSTEOCRETE as a bone void filler

Patients will be treated with Mg OSTEOCRETE as per standard clinical care to fill defects in bone left by aseptic loosening of orthopaedic hardware

DEVICE

Mg OSTEOCRETE as a bone void filler

Patients will be treated with Mg OSTEOCRETE as per standard clinical care to fill defects in bone left by trauma-related conditions

Sponsors & Collaborators

  • Bone Solutions Inc

    collaborator UNKNOWN

  • Santiago Lozano-Calderon

    lead OTHER

Principal Investigators

  • Santiago A Lozano-Calderon, MD, PhD · Massachusetts General Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-03-17
Primary Completion
2027-03-17
Completion
2028-03-17
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06720142 on ClinicalTrials.gov